2010 DDP Awards: Partnering Excellence Nominee: Partners in Care

Partnership: Partnering across the health value chain

Partners in Care has used technology to identify gaps in care, communicate the adherence/persistence needs in chronic care to providers and suppliers, and produce exemplary results in total health management. Where others thought disease management could deliver, Partners in Care showed that patient centered care, through PCMH as well as Care Coordination Entities (expanded care teams armed with data and solutions), could deliver a better dividend that mattered to the patient, the employer and the health plan. They can create these replicable and sustainable results to drive value and increase financial strength across the entire supply chain. That drives value to the demand side of the chain, and THAT drives value across the whole health value chain--promoting individual health, physician competence, and community health.

The winners will be announced at an awards ceremony on Tuesday, January 26 at the Drug Delivery Partnerships International Conference.

Share this article with your social network, just click below to share now!

Share |

2010 DDP Awards: Pipeline Value Creation Nominee: Centric Health Resources

Value Creation: Direct distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services

Centric Health Resources is a new generation, Patient-Centered Health Management® organization, serving patients with rare, orphan, and ultra-orphan disorders. Centric has a deep understanding of the value of personalized relationships, helping biotech and pharmaceutical manufacturers to better serve this targeted market niche, which is typically defined as relatively small patient populations of less than 10,000.

Centric pioneered the direct distribution model, which virtually eliminates the costs and resources associated with multiple touch points for getting the specialty product into the hands of the patient. As a result, the price of the drug remains transparent and stable, without unnecessary mark-ups that inflate costs for patients and payers. Attractive pricing reflects efficiencies associated with integration as well as lower overhead. The Centric approach allows biopharmaceutical manufacturers to leverage opportunities for cost-effective drug delivery and personalized health management services. This distinctive model improves patient compliance with therapy, drives better outcomes, and provides additional long-term support for patients and their caregivers. It also offers the opportunity for pharmaceutical companies to demonstrate value to patients, physicians and payers, adapt to a changing regulatory environment, and raise support from the patient community by engaging patient advocacy groups as partners in the provision of services.

The winners will be announced at an awards ceremony on Tuesday, January 26 at the Drug Delivery Partnerships International Conference.

Share this article with your social network, just click below to share now!

Share |